Overview

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antipsychotic Agents
Olanzapine
Quetiapine Fumarate
Risperidone